Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release.
about
The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic PotentialMediators, Receptors, and Signalling Pathways in the Anti-Inflammatory and Antihyperalgesic Effects of AcupunctureInvestigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of painSpinal botulinum neurotoxin B: effects on afferent transmitter release and nociceptive processingThe anti-inflammatory effects of acupuncture and their relevance to allergic rhinitis: a narrative review and proposed modelOxycodone combinations for pain relief.Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization.Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5Increased methylation of the MOR gene proximal promoter in primary sensory neurons plays a crucial role in the decreased analgesic effect of opioids in neuropathic pain.Peripheral mu-opioid receptors attenuate the augmented exercise pressor reflex in rats with chronic femoral artery occlusion.Pain behavior in the formalin test persists after ablation of the great majority of C-fiber nociceptorsSrc family kinases mediate the inhibition of substance P release in the rat spinal cord by μ-opioid receptors and GABA(B) receptors, but not α2 adrenergic receptors.Modulation of pain transmission by G-protein-coupled receptors.Recent advances on the δ opioid receptor: from trafficking to function.Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studies.Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesiaInflammation enhances Y1 receptor signaling, neuropeptide Y-mediated inhibition of hyperalgesia, and substance P release from primary afferent neurons.Botulinum toxin in migraine: Role of transport in trigemino-somatic and trigemino-vascular afferents.The effects of intrathecal and systemic gabapentin on spinal substance P release.Regulation of spinal substance p release by intrathecal calcium channel blockade.Spontaneous Chronic Pain After Experimental Thoracotomy Revealed by Conditioned Place Preference: Morphine Differentiates Tactile Evoked Pain From Spontaneous PainComparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibitionStress and pain response after oligofructose induced-lameness in dairy heifers.Noxious mechanical stimulation evokes the segmental release of opioid peptides that induce mu-opioid receptor internalization in the presence of peptidase inhibitors.Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists.Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of delta-opioid agonists on mechano-nociception.Dexmedetomidine and ST-91 analgesia in the formalin model is mediated by alpha2A-adrenoceptors: a mechanism of action distinct from morphineProtein kinase Cε is required for spinal analgesic synergy between delta opioid and alpha-2A adrenergic receptor agonist pairs.Effects of general anesthetics on substance P release and c-Fos expression in the spinal dorsal hornEffects of intrathecal SNC80, a delta receptor ligand, on nociceptive threshold and dorsal horn substance p release.Peripheral mechanisms of pain and analgesia.Spinal N-methyl-D-aspartate receptors and nociception-evoked release of primary afferent substance P.Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuliSpinal μ and δ opioids inhibit both thermal and mechanical pain in rats.Intrathecal P/Q- and R-type calcium channel blockade of spinal substance P release and c-Fos expression.Dynorphin B induces lateral asymmetric changes in feline spinal cord reflexes.Endomorphin-2 Inhibition of Substance P Signaling within Lamina I of the Spinal Cord Is Impaired in Diabetic Neuropathic Pain Rats.μ-Opioid receptor inhibition of substance P release from primary afferents disappears in neuropathic pain but not inflammatory pain.Calcium-permeable ion channels in pain signaling.Endogenous analgesia, dependence, and latent pain sensitization
P2860
Q26781422-E518180C-2FF4-47EF-BD41-27AA7542BCCEQ26785377-52C273A3-62AC-4CE5-97C2-923F1AAF68C4Q26863769-C7A34E33-286E-43B3-9719-757D1F43C313Q28740599-057E35EF-4796-44DD-9726-B54C3D5054F2Q30457526-D010BCBA-C8B0-4278-8549-B44C2A5197F3Q33713626-C92D2070-9E23-45A2-8E43-3DA0EA4B46F2Q33803774-867377FF-7A62-43F1-AAE7-6772C74DE975Q33976800-4CF73F19-DDB9-4A2E-A3FE-BC4718F6D997Q34062512-FD29218C-E3C7-45DC-BC5C-9706EB34DE77Q34092910-DB405214-3E33-4082-BD36-5E4E0BEE8E18Q34137293-B5F06777-E178-4DE2-BE44-FF2CC5185B54Q34142913-8AFECEF6-F820-401F-9842-3AE40E0866E1Q34247711-67A8955D-87A3-47B5-B4B4-D2772D8445B6Q34939664-EA98E532-6BCC-4382-A3D2-CD1A8D2B847AQ34957207-E435C26D-FBE1-46A3-B67E-F782D0D84B03Q34989480-7078C72F-585A-4A80-861A-39417B4A7FF7Q35186509-286C4F52-7B42-485C-A8C5-86D9DDE29C2FQ35691221-60C567FE-4EFC-4C2F-82E3-A79964040EA7Q35945726-8695065A-1F87-4625-8033-560BD26FDEA8Q35988886-0F7D4A78-63E2-4DAD-847B-69498F50E90DQ36016825-D5F3936D-5805-47AB-8154-14B72AA55D2AQ36155156-8FBA385A-C602-4353-AFED-23F2B239D508Q36431286-5E27B982-CDC9-4A8F-87CC-0FD87B02DF52Q36538158-52F2A15A-1A1A-48C4-A724-2510C8C74C76Q36628309-BF915B0D-3AD0-4AEA-92F9-D13BAE3BC3ACQ36962717-BB59C806-1D38-4007-882B-8CBBF3C88326Q37002353-B7C4CB9D-DCA5-4B1B-9BD8-4917CBF8F321Q37093923-42C2B3C3-17E5-421B-8A42-A16688E7F394Q37210075-71357192-3925-4DE9-90D3-3C12E760880EQ37252030-88260E0E-DEC9-43F9-B122-15A27C9BCE57Q37314270-A3540435-7347-4AB0-90B5-0735B08071BDQ37314774-E846AFAB-6040-415E-BE7F-4F7FD3EAED19Q37360341-E0A43F30-77CA-4859-B47C-3B5E651D24F2Q37374021-24DA6B9D-135B-4E2B-B95B-2CCC78D53FCAQ37396872-B9EFD7D3-1E82-4E82-BBF4-D76C1A5C4D42Q37397981-AC7D758B-0A1E-4F3E-A9B2-2EBFE750AB87Q37576894-0D6C163D-E26A-4291-B94F-B5A0136B85E6Q37721910-9F8A93D7-C949-42F9-B11D-1072E1A75334Q38175134-C0D0013B-F31C-4790-B4CE-71AAE0C81EC5Q38250226-C91895C1-746A-4628-B2F6-F6149CD59039
P2860
Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Inhibition by spinal mu- and d ...... nt-evoked substance P release.
@en
Inhibition by spinal mu- and d ...... nt-evoked substance P release.
@nl
type
label
Inhibition by spinal mu- and d ...... nt-evoked substance P release.
@en
Inhibition by spinal mu- and d ...... nt-evoked substance P release.
@nl
prefLabel
Inhibition by spinal mu- and d ...... nt-evoked substance P release.
@en
Inhibition by spinal mu- and d ...... nt-evoked substance P release.
@nl
P2093
P1476
Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release
@en
P2093
Bingbing Song
Frances Salgado
Ichiro Kondo
Juan Carlos G Marvizon
Tony L Yaksh
Xiao-Ying Hua
P304
P356
10.1523/JNEUROSCI.0252-05.2005
P407
P577
2005-04-01T00:00:00Z